Skip to main content
SpringerLink
Log in

The Problem of Cancer in Children

  • Chapter
Clinical Nuclear Medicine in Pediatrics

  • 1126 Accesses

Abstract

Forty percent of pediatric neoplasms develop by 4 years of age, with a slight prevalence in males, the male–female ratio being 1:1.2. In industrialized countries, the cancer incidence in children is approximately 130–140 new cases per million children a year, meaning that in Italy, for instance, there are about 1350 new pediatric cases of cancer every year. Taking all the malignant histotypes into account, recent data indicate that 70 % of patients are now still alive 5 years after their diagnosis [88].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ayan I, Kaytan E, Ayan N (2003) Childhood nasopharyngeal carcinoma: from biology to treatment. Lancet Oncol 4(1):13–21

    Article  CAS  PubMed  Google Scholar 

  2. Bacci G, Ferrari S, Bertoni F, Rimondini S, Longhi A, Bacchini P, Forni C, Manfrini M, Donati D, Picci P (2000) Prognostic factors in nonmetastatic Ewing’s sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli. J Clin Oncol 18(1):4–11

    CAS  PubMed  Google Scholar 

  3. Baldini N, Scotlandi K, Barbanti-Bròdano G, Manara MC, Maurici D, Bacci G, Bertoni F, Picci P, Sottili S, Campanacci M, Serra M (1995) Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome. N Engl J Med 333:1380–1385

    Article  CAS  PubMed  Google Scholar 

  4. Barai S, Bandopadhayaya GP, Raj P, Julka PK, Kumar R, Malhotra A, Dhanpathi H, Nainiwal S, Haloi AK (2004) Role of skeletal scintigraphy in advanced retinoblastomas. Acta Radiol 45:313–316

    Article  CAS  PubMed  Google Scholar 

  5. Barr FG (1997) Molecular genetics and pathogenesis of rhabdomyosarcoma. J Pediatr Hematol Oncol 19(6):483

    Article  CAS  PubMed  Google Scholar 

  6. Bergholm U, Bergstrom R, Ekbom A (1997) Long-term follow-up of patients with medullary carcinoma of the thyroid. Cancer 79(1):132–138

    Article  CAS  PubMed  Google Scholar 

  7. Bhatia S, Yasui Y, Robison LL, Birch JM, Bogue MK, Diller L, DeLaat C, Fossati-Bellani F, Morgan E, Oberlin O, Reaman G, Ruymann FB, Tersak J, Meadows AT (2003) High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin’s disease: report from the Late Effects Study Group. J Clin Oncol 21(23):4386–4394

    Article  PubMed  Google Scholar 

  8. Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M, Winkelmann W, Zoubek A, Jürgens H, Winkler K (2002) Prognostic factors in high-grade osteosarcomas of the extremities or trunk: an analysis of 1702 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group Protocols. J Clin Oncol 20(3):776–790

    Article  PubMed  Google Scholar 

  9. Biermann M, Schwarzmüller T, Eldevik Fasmer K, Reitan BC, Johnsen B, Rosendahl K (2013) Is there a role for PET-CT and SPECT-CT in pediatric oncology? Acta Radiol 54:1037–1045

    Article  PubMed  Google Scholar 

  10. Bonadonna G, Robustelli della Cuna G, Valagussa P (2007) Medicina Oncologica. VIII Edition Elsevier – Masson Editors, Milan

    Google Scholar 

  11. Bray F, Haugen M, Moger TA, Tretli S, Aalen OO, Grotmol T (2008) Age-incidence curves of nasopharyngeal carcinoma worldwide: bimodality in low-risk populations and aetiologic implications. Cancer Epidemiol Biomarkers Prev 17:2356–2365

    Article  PubMed  Google Scholar 

  12. Briccoli A, Rocca M, Mc S, Guzzardella GA, Balladelli A, Bacci G (2010) High-grade osteosarcoma of the extremities metastatic to the lung: long-term results in 323 patients treated combining surgery and chemotherapy, 1985–2005. Surg Oncol 19:193–199

    Article  PubMed  Google Scholar 

  13. Brisse HJ, McCarville MB, Granata C, Krug KB, Wootton-Gorges SL, Kanegawa K, Giammarile F, Schmidt M, Shulkin BL, Matthay KK, Lewington VJ, Sarnacki S, Hero B, Kaneko M, London WB, Pearson AD, Cohn SL, Monclair T (2011) Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project. Radiology 261(1):243–257

    Article  PubMed  Google Scholar 

  14. Brodeur GM, Pritchard J, Berthold F, Carlsen NLT, Castel V, Castleberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F, Kaneko M, Kemshead J, Lampert F, Lee REJ, Look AT, Pearson ADJ, Philip T, Roald B, Sawada T, Seeger RC, Tsuchida Y, Voute (1993) Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11(8):1466–1477

    CAS  PubMed  Google Scholar 

  15. Casanova M, Bisogno G, Gandola L, Cecchetto G, Di Cataldo A, Basso E, Indolfi P, D’Angelo P, Favini F, Collini P, Potepan P, Ferrari A (2012) A prospective protocol for nasopharyngeal carcinoma in children and adolescents: the Italian Rare Tumors in Pediatric Age (TREP) project. Cancer 118(10):2718–2725

    Article  PubMed  Google Scholar 

  16. Casanova M, Ferrari A, Spreafico F, Terenziani M, Massimino M, Luksch R, Cefalo G, Polastri D, Marcon I, Bellani FF (2002) Vinorelbine in previously treated advanced childhood sarcomas. Evidence of activity in rhabdomyosarcoma. Cancer 94:3263–3268

    Article  CAS  PubMed  Google Scholar 

  17. Chantada G, Doz F, Antoneli CB, Grundy R, Clare Stannard FF, Dunkel IJ, Grabowski E, Leal-Leal C, Rodríguez-Galindo C, Schvartzman E, Popovic MB, Kremens B, Meadows AT, Zucker JM (2006) A proposal for an international retinoblastoma staging system. Pediatr Blood Cancer 47(6):801–805

    Article  PubMed  Google Scholar 

  18. Cheng G, Chen W, Chamroonrat W, Torigian DA, Zhuang H, Alavi (2011) A Biopsy versus FDG PET/CT in the initial evaluation of bone marrow involvement in pediatric lymphoma patients. Eur J Nucl Med Mol Imaging 38(8):1469–1476

    Article  PubMed  Google Scholar 

  19. Cheuk DK, Sabin ND, Hossain M, Wozniak A, Naik M, Rodriguez-Galindo C, Krasin MJ, Shulkin BL et al (2012) Pet/CT for staging and follow-up of pediatric nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging 39(7):1097–1106

    Article  PubMed Central  PubMed  Google Scholar 

  20. Cheuk DK, Billups CA, Martin MG, Roland CR, Ribeiro RC, Krasin MJ, Rodriguez-Galindo C (2011) Prognostic factors and long-term outcomes of childhood nasopharyngeal carcinoma. Cancer 117(1):197–206

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  21. Chi SN, Zimmerman MA, Yao X (2009) Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol 27:385–389

    Article  PubMed Central  PubMed  Google Scholar 

  22. Chow SM, Law SC, Mendenhall WM, Au SK, Yau S, Mang O, Lau WH (2004) Differentiated thyroid carcinoma in childhood and adolescence – clinical course and role of radioiodine. Pediatr Blood Cancer 42(2):176–183

    Article  PubMed  Google Scholar 

  23. Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM, Faldum A, Hero B, Iehara T, Machin D, Mosseri V, Simon T, Garaventa A, Castel V, Matthay KK (2009) The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol 27(2):289–297

    Article  PubMed Central  PubMed  Google Scholar 

  24. Collini P, Mattavelli F, Pellegrinelli A, Barisella M, Ferrari A, Massimino M (2006) Papillary carcinoma of the thyroid gland of childhood and adolescence: morphologic subtypes, biologic behavior and prognosis. A clinicopathologic study of 42 sporadic cases treated at a single institution during a 30-year period. Am J Surg Pathol 30(11):1420–1426

    Article  PubMed  Google Scholar 

  25. Collini P, Mattavelli F, Spinelli C, Massimino M (2007) Treatment of sporadic nonmedullary thyroid carcinomas in pediatric age. Expert Rev Anticancer Ther 7(1):23–30

    Article  CAS  PubMed  Google Scholar 

  26. Costelloe CM, Chuang HH, Madewell JE (2014) FDG PET/CT of primary bone tumors. AJR Am J Roentgenol 202(6):W521–W531

    Article  PubMed  Google Scholar 

  27. Cotterill SJ, Ahrens S, Paulussen M, Jürgens HF, Voûte PA, Gadner H, Craft AW (2000) Prognostic factors in Ewing’s tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing’s Sarcoma Study Group. J Clin Oncol 18(17):3108–3114

    CAS  PubMed  Google Scholar 

  28. Danese D, Gardini A, Farsetti A, Sciacchitano S, Andreoli M, Pontecorvi A (1997) Thyroid carcinoma in children and adolescents. Eur J Pediatr 156(3):190–194

    Article  CAS  PubMed  Google Scholar 

  29. Daw NC, Billups CA, Rodriguez-Galindo C (2006) Metastatic osteosarcoma. Results of two consecutive therapeutic trials at St Jude Children’s Research Hospital. Cancer 106:403–412

    Article  PubMed  Google Scholar 

  30. Delattre O, Zucman J, Melot T, Garau XS, Zucker JM, Lenoir GM, Ambros PF, Sheer D, Turc-Carel C, Triche TJ, Aurias A, Thomas G (1994) The Ewing family of tumors – a subgroup of small round cell tumors defined by specific chimeric transcripts. N Engl J Med 331:294–299

    Article  CAS  PubMed  Google Scholar 

  31. Dolecek TA, Propp JM, Stroup NE, Kruchko C (2012) CBTRUS Statistical report: primary brain and central nervous system tumors diagnosed in the United States. In 2005–2009 Central Brain Tumor Registry of the United States, 2005. Neurooncology 14(Suppl 5):v1–v49

    Google Scholar 

  32. Ellsworth RM (1969) The practical management of retinoblastoma. Trans Am Ophthalmol Soc 67:462–534

    PubMed Central  CAS  PubMed  Google Scholar 

  33. Fagioli F, Aglietta M, Tienghi A, Ferrari S, Brach del Prever A, Vassallo E, Palmero A, Biasin E, Bacci G, Picci P, Madon E (2002) High-dose chemotherapy in the treatment of relapsed osteosarcoma: an Italian Sarcoma Group study. J Clin Oncol 20(8):2150–2156

    Article  CAS  PubMed  Google Scholar 

  34. Fangusaro J, Massimino M, Rutkowski S, Gururangan S (2010) Non-cerebellar primitive neuroectodermal tumors (PNET): summary of the Milan consensus and state of the art workshop on marrow ablative chemotherapy with hematopoietic cell rescue for malignant brain tumors of childhood and adolescents. Pediatr Blood Cancer 54(4):638–640

    Article  PubMed  Google Scholar 

  35. Ferrari A, Bono A, Baldi M, Collini P, Casanova M, Pennacchioli E, Terenziani M, Marcon I, Santinami M, Bartoli C (2005) Does melanoma behave better in younger children than in adults? A retrospective study on 33 cases of childhood melanoma from a single institution. Pediatrics 115:649–654

    Article  PubMed  Google Scholar 

  36. Ferrari A, Casanova M (2005) Current chemotherapeutic strategies for rhabdomyosarcoma. Expert Rev Anticancer Ther 5:283–294

    Article  CAS  PubMed  Google Scholar 

  37. Fleming AJ, Chi SN (2012) Brain tumors in children. Curr Probl Pediatr Adolesc Health Care 42(4):80–103

    Article  PubMed  Google Scholar 

  38. Franks LM, Bollen A, Seeger RC, Stram DO, Matthay K (1997) Neuroblastoma in adults and adolescents: an indolent course with poor survival. Cancer 79(10):2028–2035

    Article  CAS  PubMed  Google Scholar 

  39. Franzius C, Dietlein M, Biermann M, Frühwald M, Linden T, Bucsky P, Reiners C, Schober O (2007) Procedure guideline for radioiodine therapy and 131iodine whole-body scintigraphy in paediatric patients with differentiated thyroid cancer. Nuklearmedizin 46(5):224–231

    CAS  PubMed  Google Scholar 

  40. Franzius C (2010) FDG-PET/TC in pediatric solid tumours. Q J Nucl Med Imaging 54:401–410

    CAS  Google Scholar 

  41. Frustaci S, Gherlinzoni F, De Paoli A, Bonetti M, Azzarelli A, Comandone A, Olmi P, Buonadonna A, Pignatti G, Barbieri E, Apice G, Zmerly H, Serraino D, Picci P (2001) Adjuvant chemotherapy for adult soft tissue sarcomas of extremities and girdles: result of the Italian randomized cooperative trial. J Clin Oncol 19:1238–1247

    CAS  PubMed  Google Scholar 

  42. Fuchs N, Bielack SS, Epler D, Bieling P, Delling G, Körholz D, Graf N, Heise U, Jürgens H, Kotz R, Salzer-Kuntschik M, Weinel P, Werner M, Winkler K (1998) Long-term results of the Co-operative German-Austrian-Swiss Osteosarcoma Study Group’s Protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol 9:893–899

    Article  CAS  PubMed  Google Scholar 

  43. Gandola L, Massimino M, Cefalo G, Solero C, Spreafico F, Pecori E, Riva D, Collini P, Pignoli E, Giangaspero F, Luksch R, Berretta S, Poggi G, Biassoni V, Ferrari A, Pollo B, Favre C, Sardi I, Terenziani M, Fossati-Bellani F (2009) Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma. J Clin Oncol 27(4):566–571

    Article  CAS  PubMed  Google Scholar 

  44. Goorin AM, Schwartzentruber DJ, Devidas M, Gebhardt MC, Ayala AG, Harris MB, Helman LJ, Grier HE, Link MP (2003) Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. J Clin Oncol 21(8):1574–1580

    Article  CAS  PubMed  Google Scholar 

  45. Gopalakrishnan CV, Dhakoji A, Menon G (2012) Factors predicting the need for cerebrospinal fluid diversion following posterior fossa tumor surgery in children. Pediatr Neurosurg 48:93–101

    Article  CAS  PubMed  Google Scholar 

  46. Gronchi A, Casali PG, Mariani L, Miceli R, Fiore M, Lo Vullo S, Bertulli R, Collini P, Lozza L, Olmi P, Rosai J (2005) Status of surgical margins and prognosis in adult soft tissue sarcomas of the extremities: a series of 911 consecutive patients treated at a single institution. J Clin Oncol 23:96–104

    Article  CAS  PubMed  Google Scholar 

  47. Colosimo C, Gil-Nagel A, Gilhus NE, Rapoport A, Williams O (2014) Handbook of neurological therapy, chapter 39. Oxford University Press, New York

    Google Scholar 

  48. Harmer MH (1982) TNM classification of pediatric tumors. International Union Against Cancer, Geneva, pp 23–28

    Google Scholar 

  49. Hudson MM, Krasin MJ, Kaste SC (2004) PET imaging in pediatric Hodgkin’s lymphoma. Pediatr Radiol 34(3):190–198

    Article  PubMed  Google Scholar 

  50. Huvos AG (1991) Bone tumors. Diagnosis, treatment and prognosis. WH Saunders, Philadelphia

    Google Scholar 

  51. Janinis J, McTiernan A, Driver D, Mitchell C, Cassoni AM, Pringle J, Kilby A, Whelan JS (2002) A pilot study of short-course intensive multiagent chemotherapy in metastatic and axial skeletal osteosarcoma. Ann Oncol 13(12):1935–1944

    Article  CAS  PubMed  Google Scholar 

  52. Jarzab B, Handkiewicz-Junak D, Wloch J (2005) Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review. Endocr Relat Cancer 12(4):773–803

    Article  CAS  PubMed  Google Scholar 

  53. Johnson KJ, Cullen J, Barnholtz-Sloan JS, Ostrom QT, Langer CE, Turner MC, McKean-Cowdin R, Fisher JL, Lupo PJ, Partap S, Schwartzbaum JA, Scheurer ME (2014) Childhood brain tumor epidemiology: a brain tumor epidemiology consortium review. Cancer Epidemiol Biomarkers Prev 23:2716–2736

    Article  PubMed  Google Scholar 

  54. Joshi D, Anderson JR, Paidas C (2004) Age is an independent prognostic factor in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group. Ped Blood Cancer 42:64–73

    Article  CAS  Google Scholar 

  55. Kaiser J (1999) No meeting of minds on childhood cancer. Science 286:1832–1834

    Article  CAS  PubMed  Google Scholar 

  56. Kamoshima Y, Sawamura Y (2010) Update on current standard treatment in central nervous system germ cell tumors. Curr Opin Neurol 23:571–575

    Article  PubMed  Google Scholar 

  57. Kloos RT, Eng C, Evans DB, Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, Moley JF, Pacini F, Ringel MD, Schlumberger M, Wells SA Jr et al (2009) Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 19(6):565–612

    Article  PubMed  Google Scholar 

  58. Kremer N, Walther AE, Tiao GM (2014) Management of hepatoblastoma: an update. Curr Opin Pediatr 26(3):362–369

    Article  PubMed  Google Scholar 

  59. La Quaglia MP, Corbally MT, Heller G, Exelby PR, Brennan MF (1988) Recurrence and morbidity in differentiated thyroid carcinoma in children. Surgery 104(6):1149–1156

    PubMed  Google Scholar 

  60. Lanzi C, Cassinelli G, Nicolini V, Zunino F (2009) Targeting RET for thyroid cancer therapy. Biochem Pharmacol 77(3):297–309

    Article  CAS  PubMed  Google Scholar 

  61. Linn Murphree A (2005) Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin North Am 18:41–53

    Article  CAS  PubMed  Google Scholar 

  62. Lombardi F, Gandola L, Fossati-Bellani F, Gianni MC, Rottoli L, Gasparini M (1992) Hypofractionated accelerated radiotherapy in osteogenic sarcoma. Int J Radiat Oncol Biol Phys 24(4):761–765

    Article  CAS  PubMed  Google Scholar 

  63. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2007) WHO classification of tumours of the central nervous system, 4th edn. International Agency for Research on Cancer, Lyon

    Google Scholar 

  64. Massimino M, Biassoni V, Miceli R, Schiavello E, Warmuth-Metz M, Modena P, Casanova M, Pecori E, Giangaspero F, Antonelli M, Buttarelli FR, Potepan P, Pollo B, Nunziata R, Spreafico F, Podda M, Anichini A, Clerici CA, Sardi I, De Cecco L, Bode U, Bach F, Gandola L (2014) Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood. J Neurooncol 118(2):305–312

    CAS  PubMed  Google Scholar 

  65. Massimino M, Biassoni V (2006) Use of high-dose chemotherapy in front-line therapy of childhood malignant glioma. Expert Rev Anticancer Ther 6:709–717

    Article  CAS  PubMed  Google Scholar 

  66. Massimino M, Buttarelli FR, Antonelli M, Gandola L, Modena P, Giangaspero F (2009) Intracranial ependymoma: factors affecting outcome. Future Oncol 5(2):207–216

    Article  CAS  PubMed  Google Scholar 

  67. Massimino M, Collini P, Leite SF, Spreafico F, Zucchini N, Ferrari A, Mattavelli F, Seregni E, Castellani MR, Cantù G, Fossati-Bellani F, Rosai J (2006) Conservative surgical approach for thyroid and lymph-node involvement in papillary thyroid carcinoma of childhood and adolescence. Pediatr Blood Cancer 46(3):307–331

    Article  PubMed  Google Scholar 

  68. Massimino M, Giangaspero F, Garrè ML, Gandola L, Poggi G, Biassoni V, Gatta G, Rutkowski S (2011) Childhood medulloblastoma. Crit Rev Oncol Hematol 79(1):65–83

    Article  PubMed  Google Scholar 

  69. Massimino M, Solero CL, Garrè ML (2011) Second-look surgery for ependymoma: the Italian experience. J Neurosurg Pediatr 8(3):246–250

    Article  PubMed  Google Scholar 

  70. Matthay KK, Shulkin B, Ladenstein R, Michon J, Giammarile F, Lewington V, Pearson AD, Cohn SL (2010) Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force. Br J Cancer 102(9):1319–1326

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  71. Meazza C, Luksch R, Daolio P, Podda M, Luzzati A, Gronchi A, Parafioriti A, Gandola L, Collini P, Ferrari A, Casanova M, Terenziani M, Spreafico F, Polastri D, Biassoni V, Schiavello E, Pecori E, Massimino M (2014) Axial skeletal osteosarcoma: a 25-year monoinstitutional experience in children and adolescents. Med Oncol 31(4):875

    Article  PubMed  Google Scholar 

  72. Merchant TE, Hua CH, Shukla H (2008) Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function. Pediatr Blood Cancer 51:110–117

    Article  PubMed  Google Scholar 

  73. Mertens R, Granzen B, Lassay L, Gademann G, Hess CF, Heimann G (1997) Nasopharyngeal carcinoma in childhood and adolescence. Cancer 80(5):951–959

    Article  CAS  PubMed  Google Scholar 

  74. Meyers PA, Schwartz CL, Krailo MD, Healey JH, Bernstein ML, Betcher D, Ferguson WS, Gebhardt MC, Goorin AM, Harris M, Kleinerman E, Link MP, Nadel H, Nieder M, Siegal GP, Weiner MA, Wells RJ, Womer RB, Grier HE (2008) Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival. A report from the Children’s Oncology Group. J Clin Oncol 26:33–638

    Google Scholar 

  75. Mills O, Messina JL (2009) Pediatric melanoma: a review. Cancer Control 16(3):225–233

    PubMed  Google Scholar 

  76. Modena P, Buttarelli FR, Miceli R, Piccinin E, Baldi C, Antonelli M, Morra I, Lauriola L, Di Rocco C, Garrè ML, Sardi I, Genitori L, Maestro R, Gandola L, Facchinetti F, Collini P, Sozzi G, Giangaspero F, Massimino M (2012) Predictors of outcome in an AIEOP series of childhood ependymomas: a multifactorial analysis. Neuro Oncol 14(11):1346–1356

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  77. Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K, Kaneko M, London WB, Matthay KK, Nuchtern JG, von Schweinitz D, Simon T, Cohn SL, Pearson AD (2009) The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol 27(2):298–303

    Article  PubMed Central  PubMed  Google Scholar 

  78. Moroz V, Machin D, Faldum A, Hero B, Iehara T, Mosseri V, Ladenstein R, De Bernardi B, Rubie H, Berthold F, Matthay KK, Monclair T, Ambros PF, Pearson AD, Cohn SL, London WB (2011) Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project. Eur J Cancer 47(4):561–571

    Article  PubMed  Google Scholar 

  79. Murray MJ, Horan G, Lowis S, Nicholson JC (2013) Highlights from the Third International Central Nervous System Germ Cell Tumour symposium: laying the foundations for future consensus. Ecancermedicalscience 7:333

    PubMed Central  PubMed  Google Scholar 

  80. Packer RJ, Ater J, Allen J (1997) Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 86:747–754

    Article  CAS  PubMed  Google Scholar 

  81. Palmer SL, Reddick WE, Gajjar A (2007) Understanding the cognitive impact on children who are treated for medulloblastoma. J Pediatr Psychol 32:1040–1049

    Article  PubMed  Google Scholar 

  82. Panigrahy A, Blüml S (2009) Neuroimaging of pediatric brain tumors: from basic to advanced magnetic resonance imaging(MRI). J Child Neurol 24:1343–1365

    Article  PubMed  Google Scholar 

  83. Pappo AS, Shapiro DN, Crist WM, Maurer HM (1995) Biology and therapy of pediatric rhabdomyosarcoma. J Clin Oncol 13(8):2123–2139

    CAS  PubMed  Google Scholar 

  84. Pappo AS (2003) Melanoma in children and adolescents. Eur J Cancer 39(18):2651–2661

    Article  CAS  PubMed  Google Scholar 

  85. Pastorino U, Gasparini M, Tavecchio L, Azzarelli A, Mapelli S, Zucchi V, Morandi F, Bellani FF, Valente M, Ravasi G (1991) The contribution of salvage surgery in the management of childhood osteosarcoma. J Clin Oncol 9(8):1357–1362

    CAS  PubMed  Google Scholar 

  86. Paulino AC, Simon JH, Zhen W, Wen BC (2000) Long-term effects in children treated with radiotherapy for head and neck rhabdomyosarcoma. Int J Radiat Oncol Phys 48:1489–1495

    Article  CAS  Google Scholar 

  87. Parham DM (2001) Pathologic classification of rhabdomyosarcomas and correlations with molecular studies. Mod Pathol 14(5):506–514

    Google Scholar 

  88. Pizzo PA, Poplack DG (2010) Principles and practice of pediatric oncology, 6th edn. Lippincott Williams & Wilkins, Philadelphia/London

    Google Scholar 

  89. Portwine C, Mariott C, Barr RD (2010) PET imaging for pediatric oncology: an assessment of the evidence. Ped Blood Cancer 55:1048–1061

    Article  Google Scholar 

  90. Potratz J, Dirksen U, Jürgens H, Craft A (2012) Ewing sarcoma: clinical state of the art. Pediatr Hematol Oncol 29(1):1–11

    Article  CAS  PubMed  Google Scholar 

  91. Provenzi M, Saettini F, Conter V, Chinaglia D, Vai P, Bruno A, Cavalleri L, Foglia C, Giraldi E, Collini P, Spreafico F (2013) Is there a role for FDG-PET for the assessment of treatment efficacy in Wilms’ tumor? A case report and literature review. Pediatr Hematol Oncol 30(7):633–639

    Article  CAS  PubMed  Google Scholar 

  92. Puxeddu E, Romagnoli S, Dottorini ME (2011) Targeted therapies for advanced thyroid cancer. Curr Opin Oncol 23(1):13–21

    Article  CAS  PubMed  Google Scholar 

  93. Radhakrishnan V, Kumar R, Malhotra A, Bakhshi S (2012) Role of PET/CT in staging and evaluation of treatment response after 3 cycles of chemotherapy in locally advanced retinoblastoma: a prospective study. J Nucl Med 53:191–198

    Article  CAS  PubMed  Google Scholar 

  94. Raue F, Frank-Raue K (2009) Genotype-phenotype relationship in multiple endocrine neoplasia type 2. Implications for clinical management. Hormones (Athens) 8(1):23–28

    Article  Google Scholar 

  95. Ridley L, Rahman R, Brundler MA (2008) Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma. Neuro Oncol 10:675–689

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  96. Ron E, Modan B, Preston D, Alfandary E, Stovall M, Boice JD Jr (1989) Thyroid neoplasia following low-dose radiation in childhood. Radiat Res 120(3):516–531

    Article  CAS  PubMed  Google Scholar 

  97. Sardi I, Cavalieri D, Massimino M (2007) Emerging treatments and gene expression profiling in high-risk medulloblastoma. Paediatr Drugs 9(2):81–96, Review

    Article  PubMed  Google Scholar 

  98. Scuck A, Matcke AC, Scmidth B, Kunz DS, Harms D, Knietig R, Treuner J, Koscielniak E (2004) Group II rhabdomyosarcoma and rhabdomyosarcoma-like tumors: is radiotherapy necessary? J Clin Oncol 22:143–149

    Article  Google Scholar 

  99. Serin M, Erkal H, Elhan AH, Çakmak A (1998) Nasopharyngeal carcinoma in childhood and adolescence. Med Pediatr Oncol 31:498–505

    Article  CAS  PubMed  Google Scholar 

  100. Shalow EL, Broecker BH (2002) Role of surgery in children with rhabdomyosarcoma. Med Ped Oncol 38:22–32

    Article  Google Scholar 

  101. Sharma P, Jain TK, Parida GK, Karunanithi S, Patel C, Sharma A, Thulkar S, Julka PK, Bal C, Kumar R (2014) Diagnostic accuracy of integrated (18)F-FDG PET/CT for restaging patients with malignant germ cell tumours. Br J Radiol 87(1040):20140263

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  102. Simon T, Häberle B, Hero B, von Schweinitz D, Berthold F (2013) Role of surgery in the treatment of patients with stage 4 neuroblastoma age 18 months or older at diagnosis. J Clin Oncol 31(6):752–758

    Article  PubMed  Google Scholar 

  103. Sioka C (2013) The utility of FDG PET in diagnosis and follow-up of lymphoma in childhood. Eur J Pediatr 172:733–738

    Article  PubMed  Google Scholar 

  104. Smith MA, Feidlin B, Ries LAG, Simon R (1998) Trends in reported incidence of primary malignant brain tumors in children in the United States. J Natl Cancer Inst 90:1269–1277

    Article  CAS  PubMed  Google Scholar 

  105. Spinelli C, Bertocchini A, Antonelli A, Miccoli P (2004) Surgical therapy of the thyroid papillary carcinoma in children: experience with 56 patients < or =16 years old. J Pediatr Surg 39(10):1500–1505

    Article  PubMed  Google Scholar 

  106. Spunt SL, Ashley Hill D, Motosue AM, Billups CA, Cain AM, Rao BN, Pratt CB, Merchant TE, Pappo AS (2002) Clinical features and outcome of initially unresected non-metastatic pediatric non-rhabdomyosarcoma soft tissue sarcoma. J Clin Oncol 20(15):3225–3235

    Article  PubMed  Google Scholar 

  107. Stevens C, Lee JK, Sadatsafavi M, Blair GK (2009) Pediatric thyroid fine-needle aspiration cytology: a meta-analysis. J Pediatr Surg 44(11):2184–2191

    Article  PubMed  Google Scholar 

  108. Stevens MC (2005) Treatment for childhood rhabdomyosarcoma: the cost of cure. Lancet Oncol 6:77–84

    Article  PubMed  Google Scholar 

  109. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials Group (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996

    Article  CAS  PubMed  Google Scholar 

  110. van Santen HM, Aronson DC, Vulsma T, Tummers RF, Geenen MM, de Vijlder JJ, van den Bos C (2004) Frequent adverse events after treatment for childhood-onset differentiated thyroid carcinoma: a single institute experience. Eur J Cancer 40(11):1743–1751

    Article  PubMed  Google Scholar 

  111. Vokes EE, Liebowitz DN, Weichselbaum RR (1997) Nasopharyngeal carcinoma. Lancet 350:1087–1091

    Article  CAS  PubMed  Google Scholar 

  112. Warren KE, Killian K, Suuriniemi M, Wang Y, Quezado M, Meltzer PS (2012) Genomic aberrations in pediatric diffuse intrinsic pontine gliomas. Neuro Oncol 14(3):326–332

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  113. Welch Dinauer CA, Tuttle RM, Robie DK, McClellan DR, Svec RL, Adair C, Francis GL (1998) Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults. Clin Endocrinol (Oxf) 49(5):619–628

    Article  CAS  Google Scholar 

  114. Wilne SH, Ferris RC, Nathwani A, Kennedy CR (2006) The presenting features of brain tumours: a review of 200 cases. Arch Dis Child 91:502–506

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  115. Wu G, Broniscer A, McEachron TA, Lu C, Paugh BS, Becksfort J, Qu C, Ding L, Huether R, Parker M, Zhang J, Gajjar A, Dyer MA, Mullighan CG, Gilbertson RJ, Mardis ER, Wilson RK, Downing JR, Ellison DW, Zhang J, Baker SJ, St. Jude Children’s Research Hospital–Washington University Pediatric Cancer Genome Project (2012) Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44(3):251–253

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  116. Yin M, King SK, Hutson JM, Chow CW (2006) Multiple endocrine neoplasia type 2B diagnosed on suction rectal biopsy in infancy: a report of 2 cases. Pediatr Dev Pathol 9(1):56–60

    Article  PubMed  Google Scholar 

  117. Zwaveling S, Tytgat GA, van der Zee DC, Wijnen MH, Heij HA (2012) Is complete surgical resection of stage 4 neuroblastoma a prerequisite for optimal survival or may >95% tumour resection suffice? Pediatr Surg Int 28:953–959

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

    Marta Podda, Veronica Biassoni, Cristina Meazza, Elisabetta Schiavello Serena Catania & Maura Massimino

Authors
  1. Marta Podda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Veronica Biassoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cristina Meazza
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Elisabetta Schiavello Serena Catania
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Maura Massimino
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marta Podda .

Editor information

Editors and Affiliations

  1. Nuclear Medicine, Second University of Naples, Napoli, Italy

    Luigi Mansi

  2. Nuclear Medicine, Humanitas Research Hospital, Rozzano, Milano, Italy

    Egesta Lopci

  3. Nuclear Medicine, Second University of Naples, Napoli, Italy

    Vincenzo Cuccurullo

  4. Nuclear Medicine, Humanitas Research Hospital, Rozzano, Milano, Italy

    Arturo Chiti

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Podda, M., Biassoni, V., Meazza, C., Catania, E.S.S., Massimino, M. (2016). The Problem of Cancer in Children. In: Mansi, L., Lopci, E., Cuccurullo, V., Chiti, A. (eds) Clinical Nuclear Medicine in Pediatrics. Springer, Cham. https://doi.org/10.1007/978-3-319-21371-2_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-21371-2_11

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-21370-5

  • Online ISBN: 978-3-319-21371-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation